Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation

This publication has 19 references indexed in Scilit:

• Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting
  Circulation, 2000
• Evaluation of Platelet Function by Flow Cytometry
  Methods, 2000
• Clopidogrel
  Drugs, 1997
• Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy
  Journal of the American College of Cardiology, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
  New England Journal of Medicine, 1996
• Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent
  Cardiovascular Drug Reviews, 1993
• Characterization of GMP-140 (P-selectin) as a circulating plasma protein.
  The Journal of Experimental Medicine, 1992
• The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb–IIIa complex in rat and in man
  Biochemical Pharmacology, 1990